Nuclear Medicine for all Canadians
Company Creation
Since the launch of the company in 2008,
CPDC has created or supported the
spin-off for four radiopharmaceutical
companies in Canada.
Since the launch of the company in 2008, CPDC has created or supported the spin-off for four radiopharmaceutical companies in Canada.
From Concept to Clinic to
Commercialization.
From Concept to Clinic to the Commercial Market.
Your radiopharmaceutical development partner.
At CPDC we are working with our partners
to discover and develop the next generation
of imaging agents and targeted
radiotherapeutics for the detection and
treatment of human diseases.
to discover and develop the next generation
of imaging agents and targeted
radiotherapeutics for the detection and
treatment of human diseases.
At CPDC we are working with our partners to discover and develop the next generation of imaging agents and targeted radiotherapeutics for the detection and treatment of human diseases.
Current Programs
CPDC has ongoing programs in the
clinical, preclinical and discovery stages
targeting PSMA in prostate cancer,
evaluating LAT1 expression, as well as various other oncology and neurology diseases.
CPDC has on-going programs in the
clinical, preclinical and discovery stages targeting PSMA in prostate cancer, monitoring CD8-mediated immune response, as well as various other cancer and neurology targets.
See our programs in detail here
Careers
Do you love
radiopharmaceuticals as
much as we do?
Do you love radiopharmaceuticals as much as we do?
CPDC is always looking for exceptional people to strengthen our team.
Latest News
2023.27.06
